Design and features of the Acorn CorCap™ Cardiac Support Device: The concept of passive mechanical diastolic support

Heart Failure Reviews

Volumn 10, Issue 2, 2005, Pages 101-107

  Walsh, Robert G ^a  

^a Acorn Cardiovascular Inc   (United States)

Author keywords

Compliance; CorCap cardiac support device; Heart failure; Passive constraint; Wall stress

Indexed keywords

ARTICLE; BIOENGINEERING; DEVICE; DISEASE COURSE; EQUIPMENT DESIGN; HEART CONTRACTION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE TENSION; HUMAN; MATHEMATICAL COMPUTING; SURGICAL TECHNIQUE;

CARDIOMYOPATHY, DILATED; DIASTOLE; EQUIPMENT DESIGN; HEART-ASSIST DEVICES; HUMANS; MATERIALS TESTING; VENTRICULAR REMODELING;

EID: 27944457988     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-005-4637-x     Document Type: Article

References (44)

1. Packer M. The impossible task of developing a new treatment for heart failure. J Cardiac Failure 2002;8(4):193-196. 10.1054/jcaf.2002.128001
2. Chen FY, Cohn LH. The surgical treatment of heart failure. A new frontier: Nontransplant surgical alternatives in heart failure. Cardiol Rev 2002;10(8):326-333. 10.1097/00045415-200211000-00004
3. Loebe M, Soltero E, Thohan V, Lafuente JA, Noon Gp. New surgical therapies for heart failure. Curr Opin Cardiol 2003;18:194-198. 10.1097/ 00001573-200305000-00004
4. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schondube F, Wolfhard U, Bocker D, Krahnefeld O, Kirkels H; Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39(12):2026-2033. 10.1016/S0735-1097(02)01895-8
5. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346(24):1845-1853. 10.1056/NEJMoa013168
6. GJ Magovern KA Simpson JA Magovern GJ Magovern Sr. 1998 Surgical therapy for heart failure In: EA Rose LW Stevenson eds. Management of End-Stage Heart Disease Lippincott-Raven Publishers Philadelphia 231-239
7. Magovern GJ, et al., 1998.
8. Chachques JC, Berrebi A, Hernigou A, Cohen-Solal A, Lavergne T, Marino JP, D'Attellis N, Bensasson D, Carpentier A. Study of muscular and ventricular function in dynamic cardiomyoplasty: A ten-year follow-up. J Heart Lung Transplant 1997;16:854-868. 9286778
9. Lorusso R, Milan E, Volterrani M, Giubbini R, van der Veen FH, Schreuder JJ, Picchioni A, Alfieri O. Cardiomyoplasty as an isolated procedure to treat refractory heart failure. Eur J Cardiothorac Surg 1997;11:363-372. 10.1016/S1010-7940(96)01038-X
10. Oh JH, Badhwar V, Chiu RC. Mechanisms of dynamic cardiomyoplasty: Current concepts. J Card Surg 1996;11:194-199. 8889879
11. El Oakley RM, Jarfis JC. Cardiomyoplasty: A critical review of experimental and clinical results. Circ 1994;90:2085-2090.
12. Capouya ER, Gerber RS, Drinkwater DC, Pearl JM, Sack JB, Aharon AS, Barthel SW, Kaczer EM, Chang PA, Laks H. Girdling effect of nonstimulated cardiomyoplasty on left ventricular function. Ann Thorac Surg 1993;56:867-871. 8215663
13. R Shabetai 1985 Function In: NO Fowler ed. The Pericardium in Health and Disease Futura Mount Kisco, NY 19-50
14. Shabetai R. Function of the normal pericardium. Clin Cardiol 1999;22(1 Suppl 1):I4-I5. 9929760
15. Freeman G.L. The effects of the pericardium on function of normal and enlarged hearts Cardiol Clin 1990 8 4 579-586 2147401
16. Freeman GL, LeWinter MM. Pericardial adaptations during chronic cardiac dilation in dogs. Circ Res 1984;54(3):294-300. 6230171
17. Capouya ER, Gerber RS, Drinkwater DC, Pearl JM, Sack JB, Aharon AS, Barthel SW, Kaczer EM, Chang PA, Laks H. Girdling effect of nonstimulated cardiomyoplasty on left ventricular function. Ann Thorac Surg 1993;56:867-871. 8215663
18. Vaynblat M, Chiavarelli M, Shah HR, Ramdev G, Aron M, Zisbrod Z, Cunningham JN Jr. Cardiac binding in experimental heart failure. Ann Thorac Surg 1997;64:81-85. 10.1016/S0003-4975(97)00349-4
19. Patel HJ, Polidori DJ, Pilla JJ, Plappert T, Kass D, St. John Sutton M, Lankford EB, Acker MA. Stabilization of chronic remodeling by asynchronous cardiomyoplasty in dilated cardiomyopathy: Effects of a conditioned muscle wrap. Circ 1997;96:3665-3671.
20. Oh JH, Badhwar V, Mott BD, Li CM, Chiu RC-J. The effects of prosthetic cardiac binding and adynamic cardiomyoplasty in a model of dilated cardiomyopathy. J Thorac Cardiovasc Surg 1998;116:148-153. 9671909
21. Kass DA, Baughman KL, Pak PH, Cho PW, Levin HR, Gardner TJ, Halperin HR, Tsitlik JE, Acker MA. Reverse remodeling from cardiomyoplasty in human heart failure: External constraint versus active assist. Circ 1995;91:2314-2318. 7729016
22. Hagege AA, Desnos M, Fernandez F, Besse B, Mirochnik N, Castaldo M, Chachques JC, Carpentier A, Guerot C. Clinical study of the effects of latissimus dorsi muscle flap stimulation after cardiomyoplasty. Circ 1995;92(9 Suppl):II-210-II-215.
23. Patel HJ, Lankford EB, Polidori DJ, Pilla JJ, Plappert T, Sutton MSJ, Acker MA. Dynamic cardiomyoplasty: Its chronic and acute effects on the failing heart. J Thorac Cardiovasc Surg 1997;114:169-178. 9270632
24. Kass DA, et al., 1995.
25. Leier CV. Cardiomyoplasty: Is it time to wrap it up? J Am Coll Cardiol 1997;28:1182-1183.
26. Vaynblat M, et al., 1997.
27. Oh JH, et al., 1998.
28. Chaudhry PA, Mishima T, Sharov VG, Hawkins J, Alferness C, Paone G, Sabbah HN. Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg 2000;70:1275-1280. 10.1016/ S0003-4975(00)01755-0
29. Saavedra WF, Tunin RS, Paolocci N, Mishima T, Suzuki G, Emala CW, Chaudhry PA, Anagnostopoulos P, Gupta RC, Sabbah HN, Kass DA. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J Am Coll Cardiol 2002 Jun 19;39(12):2069-76. 10.1016/S0735-1097(02)01890-9 Jun 19
30. Oz MC, Konertz WF, Kleber FX, Mohr FW, Gummert JF, Ostermeyer J, Lass M, Raman J, Acker MA, Smedira N. Global surgical experience with the Acorn cardiac support device. J Thorac Cardiovasc Surg 2003 Oct;126(4):983-991.
31. Mary C, Marois Y, King MW, Hong T, Laroche G, Douville Y, Martin L, Guidoin R: In vitro and in vivo studies of a polyester arterial prosthesis with a warp-knitted sharkskin structure. J Biomed Mater Res 1997;35:459-472. 10.1002/ (SICI)1097-4636(19970615)35:4<459::AID-JBM6>3.0.CO;2-G
32. Seitz H, Marlovits S, Schwendenwein I, Muller E, Vecsei V: Biocompatibility of polyethylene terephthalate (Trevira hochfest) augmentation device in repair of the anterior cruciate ligament. Biomaterials 1998;19:189-196. 10.1016/S0142-9612(97)00201-9
33. Guidoin RG, King M, Marois M, Martin L, Marceau D, Hood R, Maini R: New polyester arterial prostheses from Great Britain: An in vitro and in vivo evaluation. Ann Biomed Eng 1986;14:351-367. 2944457
34. D.F. Paling 1970 Warp Knitting Technology Columbine Press Ltd. Buxton, Great Britain 111 pp
35. Nunn DB: Structural failure of Dacron arterial grafts. Semin Vasc Surg 1999;12:83-91. 10100389
36. Vinard E, Eloy R, Descotes J, Brudon JR, Guidicelli H, Magne JL, Patra P, Berruet R, Huc A, Chauchard J: Stability of performances of vascular prostheses retrospective study of 22 cases of human implanted prostheses. J Biomed Mater Res 1988;22:633-648. 10.1002/jbm.820220705
37. Riepe G, Loos J, Imag H, Schroder A, Schneider E, Permann J, Rogge A, Ludwig M, Schenke A, Nassutt R, Chakfe N, Morlock M: Long-term in vivo alterations of polyester vascular grafts in humans. Eur J Vasc Endovasc Surg 1997;13:540-548. 10.1016/S1078-5884(97)80062-7
38. Francis GS. Neurohumoral activation and progression of heart failure: Hypothetical and clinical considerations. J Cardiovasc Pharmacol 1998;32(Suppl 1):S16-S21. 10.1097/00005344-199800003-00004
39. Middlekauff HR. Mechanisms and implications of autonomic nervous system dysfunction in heart failure. Curr Opin Cardiol 1997;12(3):265-275. 9243084
40. Baig MK, Mahon N, McKenna WJ, Caforio ALP, Bonow RO, Francis GS, Gheorghiade M. The pathophysiology of advanced heart failure. Heart & Lung 1999;28:87-101.
41. Dreifuss P. therapy of terminal dilated cardiomyopathy with growth hormone. Z Kardiol 1998;87:425-435. 10.1007/s003920050197
42. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circ 1990;81:1161-1172. 2138525
43. Baig, MK, et al., 1999.
44. Testing according to ASTM Standard D3787-89.